Belgin Sever

1.9k total citations
79 papers, 1.6k citations indexed

About

Belgin Sever is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Belgin Sever has authored 79 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Organic Chemistry, 30 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Belgin Sever's work include Synthesis and biological activity (41 papers), Synthesis and Characterization of Heterocyclic Compounds (19 papers) and Enzyme function and inhibition (10 papers). Belgin Sever is often cited by papers focused on Synthesis and biological activity (41 papers), Synthesis and Characterization of Heterocyclic Compounds (19 papers) and Enzyme function and inhibition (10 papers). Belgin Sever collaborates with scholars based in Türkiye, Japan and United States. Belgin Sever's co-authors include Mehlika Dilek Altıntop, Ahmet Özdemır, Şükrü Beydemir, Yeliz Demir, Gülşen Akalın Çiftçi, Zafer Asım Kaplancıklı, Halil I. Ciftci, Mikako Fujita, Masami Otsuka and Gülşen Akalın Çiftçi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Belgin Sever

75 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belgin Sever Türkiye 23 951 631 249 187 143 79 1.6k
Ahmed Elkamhawy South Korea 24 506 0.5× 601 1.0× 184 0.7× 244 1.3× 131 0.9× 67 1.4k
Nishant Jain India 26 1.4k 1.4× 880 1.4× 186 0.7× 177 0.9× 111 0.8× 86 2.2k
Mehlika Dilek Altıntop Türkiye 32 2.0k 2.1× 817 1.3× 456 1.8× 320 1.7× 351 2.5× 111 2.8k
Alessia Bertamino Italy 22 469 0.5× 670 1.1× 124 0.5× 137 0.7× 85 0.6× 83 1.5k
Hamed I. Ali Egypt 27 786 0.8× 675 1.1× 323 1.3× 141 0.8× 157 1.1× 60 1.6k
Matteo Incerti Italy 22 1.2k 1.3× 581 0.9× 212 0.9× 283 1.5× 135 0.9× 67 2.0k
Xuewei Wu China 15 463 0.5× 693 1.1× 127 0.5× 212 1.1× 84 0.6× 28 1.3k
Shilong Zheng United States 29 935 1.0× 1.2k 1.8× 209 0.8× 409 2.2× 105 0.7× 79 2.3k
Dongsoo Koh South Korea 22 544 0.6× 554 0.9× 260 1.0× 193 1.0× 60 0.4× 126 1.3k
Roberta Bortolozzi Italy 28 1.4k 1.4× 798 1.3× 171 0.7× 258 1.4× 80 0.6× 74 2.1k

Countries citing papers authored by Belgin Sever

Since Specialization
Citations

This map shows the geographic impact of Belgin Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belgin Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belgin Sever more than expected).

Fields of papers citing papers by Belgin Sever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belgin Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belgin Sever. The network helps show where Belgin Sever may publish in the future.

Co-authorship network of co-authors of Belgin Sever

This figure shows the co-authorship network connecting the top 25 collaborators of Belgin Sever. A scholar is included among the top collaborators of Belgin Sever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belgin Sever. Belgin Sever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sever, Belgin, Canan Sevimli-Gür, Mustafa Can, et al.. (2025). Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds. Pharmaceuticals. 18(2). 270–270. 9 indexed citations
2.
3.
Sever, Belgin, Masami Otsuka, Mikako Fujita, & Halil I. Ciftci. (2024). A Review on FDA Approved Anti-HIV-1 Drugs, Anti-Gag Compounds and Potential Strategies for HIV-1 Eradication. Preprints.org. 7 indexed citations
4.
Sever, Belgin, Abdulilah Ece, Hiroshi Tateishi, et al.. (2023). Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives. Pharmaceuticals. 16(11). 1608–1608. 4 indexed citations
5.
Altıntop, Mehlika Dilek, Gülşen Akalın Çiftçi, Belgin Sever, et al.. (2023). Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International Journal of Molecular Sciences. 24(3). 2648–2648. 10 indexed citations
6.
Altıntop, Mehlika Dilek, Ahmet Özdemır, Halide Edip Temel, et al.. (2022). Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer. European Journal of Medicinal Chemistry. 244. 114851–114851. 10 indexed citations
7.
Küçükoğlu, Kaan, et al.. (2022). Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents. Journal of Molecular Structure. 1276. 134699–134699. 8 indexed citations
8.
Temel, Halide Edip, Mehlika Dilek Altıntop, Belgin Sever, Ahmet Özdemır, & Gülşen Akalın Çiftçi. (2022). In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors. SHILAP Revista de lepidopterología. 48(1). 104–109. 1 indexed citations
9.
Altıntop, Mehlika Dilek, et al.. (2022). A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition. Archiv der Pharmazie. 355(9). e2200136–e2200136. 3 indexed citations
10.
Özdemır, Ahmet, Halil I. Ciftci, Belgin Sever, et al.. (2022). A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy. Molecules. 27(2). 485–485. 11 indexed citations
11.
Sever, Belgin, Mehlika Dilek Altıntop, Yeliz Demir, et al.. (2021). Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. Chemico-Biological Interactions. 345. 109576–109576. 64 indexed citations
12.
Ciftci, Halil I., Mohamed O. Radwan, Belgin Sever, et al.. (2021). EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy. International Journal of Molecular Sciences. 22(20). 10945–10945. 27 indexed citations
13.
Sever, Belgin, Mehlika Dilek Altıntop, Yeliz Demir, et al.. (2020). An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives. Journal of Molecular Structure. 1224. 129446–129446. 58 indexed citations
14.
Sever, Belgin, Mehlika Dilek Altıntop, Ahmet Özdemır, et al.. (2020). In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules. 25(21). 5190–5190. 45 indexed citations
15.
Altıntop, Mehlika Dilek, Belgin Sever, Ahmet Özdemır, et al.. (2020). A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 21(9). 1099–1109. 15 indexed citations
16.
Sever, Belgin, et al.. (2020). Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects. Molecules. 25(21). 5003–5003. 20 indexed citations
17.
Sever, Belgin, Mehlika Dilek Altıntop, & Halide Edip Temel. (2020). In vitro and in silico studies on AChE inhibitory effects of a series of donepezil-like arylidene indanones. Turkish Journal of Biochemistry. 45(4). 359–363. 4 indexed citations
18.
Özdemır, Ahmet, et al.. (2018). Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress. Molecules. 23(9). 2151–2151. 18 indexed citations
19.
Altıntop, Mehlika Dilek, Belgin Sever, Gülşen Akalın Çiftçi, & Ahmet Özdemır. (2018). Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors. Molecules. 23(6). 1318–1318. 58 indexed citations
20.
Altıntop, Mehlika Dilek, Belgin Sever, Gülşen Akalın Çiftçi, et al.. (2018). Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors. European Journal of Medicinal Chemistry. 155. 905–924. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Elkamhawy Breakdown of academic impact, for papers by Nishant Jain Breakdown of academic impact, for papers by Mehlika Dilek Altıntop Breakdown of academic impact, for papers by Alessia Bertamino Breakdown of academic impact, for papers by Hamed I. Ali Breakdown of academic impact, for papers by Matteo Incerti Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Shilong Zheng Breakdown of academic impact, for papers by Dongsoo Koh Breakdown of academic impact, for papers by Roberta Bortolozzi
Rankless by CCL
2026